ArticleSignal transduction and targeted therapy2025

Preclinical CSF proteomic changes: a milestone in biomarker detection for autosomal dominant Alzheimer's disease.

J Alexander Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.